In his presentation at Ending Age-Related Diseases 2020, investor Sergey Young discussed the potential of a trillion-dollar market, proactive versus reactive medicine, demographic changes throughout the world, technology integration, the potential of regenerative medicine, the role of capital in rejuvenation biotechnology, and many other related topics.